Research Article
Dry Powder and Budesonide Inhalation Suspension Deposition Rates in Asthmatic Airway-Obstruction Regions
Table 3
Budesonide particle size by application device per Cascade Impactor. On budesonide inhalation therapies NE-C28 and NE-U22 have advantage of 78% and 59% with 2 < particle size < 6 µm respectively. These data are double deposit percentage of Turbohaler and Symbicort dry powder.
|